Abeona Therapeutics (ABEO) Net Equity Issued and Repurchased (2009 - 2025)
Abeona Therapeutics (ABEO) posted Net Equity Issued and Repurchased of $3.61 million for Q4 2025, down 34.4% from $5.51 million a year earlier and down 30.0% from the prior quarter.
Abeona Therapeutics (ABEO) Net Equity Issued and Repurchased (2009 - 2025) Analysis & Trends
For FY2025, Abeona Therapeutics' Net Equity Issued and Repurchased came in at $26.08 million, down 69.5% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 171.1% (FY2020 to FY2025).
- In prior years, Abeona Therapeutics' Net Equity Issued and Repurchased was $85.63 million in FY2024 (+129.0%), $37.39 million in FY2023 (+9.6%), $34.12 million in FY2022 (+323.8%) and $8.05 million in FY2021.
- The Q4 2025 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q4 2022.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in 1 of the last four quarters, with an average decline of 35.9%.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $5.16 million (Q3 2025), $10.5 million (Q2 2025) and $6.8 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Abeona Therapeutics | 149.28 Mn | -492.16 Mn | 7.78 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.61 Mn |
| Sep 30, 2025 | 5.16 Mn |
| Jun 30, 2025 | 10.50 Mn |
| Mar 31, 2025 | 6.80 Mn |
| Dec 31, 2024 | 5.51 Mn |
| Jun 30, 2024 | 73.70 Mn |
| Mar 31, 2024 | 6.42 Mn |
| Dec 31, 2023 | 7.79 Mn |
| Sep 30, 2023 | 22.98 Mn |
| Dec 31, 2022 | -26.22 Bn |
| Dec 31, 2021 | -479,000.00 |
| Sep 30, 2021 | 173,000.00 |
| Jun 30, 2021 | 2.48 Mn |
| Mar 31, 2021 | 5.88 Mn |
| Dec 31, 2020 | 3,000.00 |
| Dec 31, 2019 | -95.42 Mn |
| Sep 30, 2019 | 4.34 Mn |
| Jun 30, 2019 | 13.01 Mn |
| Mar 31, 2019 | 28,000.00 |
| Dec 31, 2018 | -1,000.00 |
Abeona Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ABEO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ABEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ABEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();